Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-22T07:21:19.746Z Has data issue: false hasContentIssue false
  • English
  • Français

Clomipramine and ‘Drive’ in People with Anorexia Nervosa: An In-patient Study

Published online by Cambridge University Press:  02 January 2018

A. H. Crisp ,
J. H. Lacey  and
M. Crutchfield
A. H. Crisp*
Affiliation:
St George's Hospital Medical School
J. H. Lacey
Affiliation:
St George's Hospital Medical School
M. Crutchfield
Affiliation:
Sleep Laboratory, Atkinson Morley's Hospital, London SW20
*
∗St George's Hospital Medical School, Cranmer Terrace, London SW17 0RE
Get access Rights & Permissions [Opens in a new window]

Abstract

Drugs can sometimes be helpful within the overall treatment and management of anorexia nervosa. In this study we have examined the impact of clomipramine on food and activity in anorectics engaged in a treatment programme enabling them to regain normal body weight. Consumption of the drug was associated with increased appetite, hunger and calorie consumption during the early stages of treatment. There was no impact on ultimate outcome. In this study it was evident that the drug was unnecessary for weight gain, but it may be helpful in other programmes, both short and long term, where the patient has sufficient trust (to tolerate the enhanced hunger experience) but is not involved in the same behavioural constraints. However, its possible value in such programmes has not been proven here. Meanwhile, we take our findings as further evidence that clomipramine increases drive behaviour and appetite in humans and may be beneficial in the treatment of affective disorders because of this effect.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 150 , Issue 3 , March 1987 , pp. 355 - 358
Copyright
Copyright © 1987 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Crisp, A. H. (1967) The possible significance of some behavioural correlates of weight and carbohydrate intake. Journal of Psychosomatic Research, 11, 117–131.Google Scholar
Crisp, A. H. (1978) Disturbances of neurotransmitter metabolism in anorexia nervosa. Proceedings of the Nutritional Society, 37, 151–159.Google Scholar
Crisp, A. H. (1980a) Anorexia Nervosa: Let Me Be. London: Academic Press.Google Scholar
Crisp, A. H. (1980b) Sleep, activity, nutrition and mood. British Journal of Psychiatry, 137, 1–7.CrossRefGoogle ScholarPubMed
Crisp, A. H. (1984) Treatment of anorexia nervosa: what can be the role of psychopharmacological agents? In The Psychobiology of Anorexia Nervosa (eds K. M. Pirke & D. Ploog). Heidelberg: Springer- Verlag.Google Scholar
Crisp, A. H. (1986) ‘Biogical’ depression; because sleep fails? Postgraduate Medical Journal, 62, 179–185.CrossRefGoogle Scholar
Crisp, A. H., Stonehill, E. & Eversden, I. D. (1970) The design of a motility bed including its calibration for the subject's weight. Medical and Biological Engineering, 8, 455–463.Google Scholar
Hsu, L. K. G., Crisp, A. H. & Harding, B. (1979) Outcome of anorexia nervosa. Lancet, i, 62–65.Google Scholar
Lacey, J. H. & Crisp, A. H. (1980) Hunger, food intake and weight; the impact of clomipramine on a refeeding anorexia nervosa population. Postgraduate Medical Journal, 56, (suppl. 1), 79–85.Google ScholarPubMed
Morgan, H. G. & Russell, G. F. M. (1975) Value of family background and clinical features as predictors of longterm outcome in anorexia nervosa: four-year study of 41 patients. Psychological Medicine, 5, 355–371.Google Scholar
Paykel, E. S. (1977) Depression, antidepressant drugs and appetite. In Depression -the Biochemical and Physiological Role of Ludiomil (ed. A. Jukes). Horsham: CIBA Laboratories.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.